Suppr超能文献

[抗抑郁药物的长期治疗]

[Long-term treatment with antidepressive drugs].

作者信息

Lôo H, Brochier T

机构信息

Service Hospitalo-Universitaire de Santé Mentale et de Thérapeutique, Centre Hospitalier Sainte-Anne, Paris.

出版信息

Ann Med Psychol (Paris). 1995 May;153(3):190-6; discussion 196-7.

PMID:7598353
Abstract

Distinction between relapse and recurrence is a major difficulty in studies assessing the efficacy of long term antidepressant treatment. A four to six months symptom-free period is required to talk of recovery from depression and plan a preventive treatment, i.e. prevention of recurrence. Compounds are not selected according to their biochemical profile; the most recent antidepressant drugs were studied in that indication through long term controlled trials. In unipolar patients, recent studies favour the prescription of high doses of antidepressant drugs during at least five years. In bipolar patients, combination of long term antidepressant to lithium treatment may be of benefit to patients whose index episode was of depressive type, but appears useless in other cases. In all cases, joint psychotherapy and the quality of the relationship between the patient and the prescribing physician influence compliance and outcome. Dysthymia, panic disorder and obsessive-compulsive disorder constitute other acknowledged cases for long term prescription of antidepressants. These indications remain empirical till controlled trials have not specifically assessed each antidepressant compound.

摘要

在评估长期抗抑郁治疗疗效的研究中,区分复发和再发是一个主要难点。从抑郁症康复并计划预防性治疗(即预防再发)需要四到六个月的无症状期。化合物并非根据其生化特性来选择;最新的抗抑郁药物是通过长期对照试验在该适应症中进行研究的。在单相患者中,近期研究倾向于至少五年内开具高剂量抗抑郁药物。在双相患者中,长期抗抑郁药物与锂盐治疗联合使用可能对首发为抑郁型发作的患者有益,但在其他情况下似乎并无用处。在所有情况下,联合心理治疗以及患者与开处方医生之间关系的质量会影响依从性和治疗结果。恶劣心境障碍、惊恐障碍和强迫症是长期开具抗抑郁药物的其他公认病例。在对照试验尚未专门评估每种抗抑郁化合物之前,这些适应症仍基于经验。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验